Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lubetzki

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
La Revue Du Praticien|September 5, 2006
[Therapeutic perspectives in multiple sclerosis]Catherine Lubetzki
Bulletin De L'Academie Nationale De Medecine|October 15, 2003
[The remyelination phenomenon in multiple sclerosis]Catherine Lubetzki
Bulletin De L'Academie Nationale De Medecine|September 30, 2008
[Regenerative capacity in multiple sclerosis]Catherine Lubetzki
Bulletin De L'Academie Nationale De Medecine|May 17, 2011
[Multiple sclerosis: emerging treatments]Catherine Lubetzki
The Lancet. Neurology|December 4, 2018
150 years since Charcot's lectures on multiple sclerosisCatherine Lubetzki
Medecine Sciences : M/S|December 21, 2013
[New challenges in multiple sclerosis treatment]Catherine Lubetzki
Current Opinion in Neurology|May 3, 2008
Demyelinating diseases. EditorialCatherine Lubetzki
The Lancet. Neurology|December 19, 2020
Multiple sclerosis in 2020: un bon cruElisabeth Maillart, Catherine Lubetzki
Brain : a Journal of Neurology|September 12, 2022
Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?Vanja Tepavčević, Catherine Lubetzki
The Lancet. Neurology|July 24, 2020
Remyelination: a brief historyCatherine Lubetzki, Bernard Zalc
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
La Revue Du Praticien|September 5, 2006
[Therapeutic perspectives in multiple sclerosis]Catherine Lubetzki
Bulletin De L'Academie Nationale De Medecine|October 15, 2003
[The remyelination phenomenon in multiple sclerosis]Catherine Lubetzki
Bulletin De L'Academie Nationale De Medecine|September 30, 2008
[Regenerative capacity in multiple sclerosis]Catherine Lubetzki
Bulletin De L'Academie Nationale De Medecine|May 17, 2011
[Multiple sclerosis: emerging treatments]Catherine Lubetzki
The Lancet. Neurology|December 4, 2018
150 years since Charcot's lectures on multiple sclerosisCatherine Lubetzki
Medecine Sciences : M/S|December 21, 2013
[New challenges in multiple sclerosis treatment]Catherine Lubetzki
Current Opinion in Neurology|May 3, 2008
Demyelinating diseases. EditorialCatherine Lubetzki
The Lancet. Neurology|December 19, 2020
Multiple sclerosis in 2020: un bon cruElisabeth Maillart, Catherine Lubetzki
Brain : a Journal of Neurology|September 12, 2022
Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?Vanja Tepavčević, Catherine Lubetzki
The Lancet. Neurology|July 24, 2020
Remyelination: a brief historyCatherine Lubetzki, Bernard Zalc
Pageof 14